Earnings Call · Q1 FY2026·2026-05-04

Q1 26EPS -5.00%·Rev n/aQ4 25EPS +86.59%·Rev n/aQ3 25EPS +16.67%·Rev n/aQ2 25EPS -4.17%·Rev n/a⚠ consensus missing

ADC Therapeutics SA ADCT

Nicole Riley — Head of Investor Relations and Corporate Communications

Ameet Mallik — Chief Executive Officer

Jose Carmona — Chief Financial Officer

−3.9%1d on move date−3.6% vs SPY3d+0.8%5d−8.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADCT calls or request research access.

More ADCT calls Browse calls Request research access